TAKEDA PHARMACEUTICAL COMPANY LIMITED

Estimates Revisions Takeda Pharmaceutical Company Limited Sapporo S.E.

Stocks

4502

JP3463000004

Pharmaceuticals

Delayed Sapporo S.E. 20:00:00 2026-05-17 EDT			5-day change	1st Jan Change
5,330.00 ^JPY	+0.76%		+0.76%	+21.41%

09-14	Takeda Pharmaceutical Company Limited Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 02:35 PM
09-14	Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Monday Trading	MT

Turnover - Evolution of Analysts' Estimates

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Data source: Takeda Pharmaceutical Company Limited(4502)

EBIT - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Data source: Takeda Pharmaceutical Company Limited(4502)

Cash or Net Debt - Evolution of Analysts' Estimates

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.

See all sector revisions

Turnover

Earnings Per Share (EPS)

Data source: Takeda Pharmaceutical Company Limited(4502)

EBIT

Dividend / Share (DPS)

Data source: Takeda Pharmaceutical Company Limited(4502)

Cash or Net Debt

Stock Market
Stocks
4502 Stock
4502 Stock
Consensus Takeda Pharmaceutical Company Limited
Estimates Revisions

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!